Navamedic ASA acquires innovative antibiotic product for hospital use in the Nordic region
Oslo, 23 November 2022 - Navamedic has signed an agreement with its partner InfoRLife SA (subsidiary of ACS Dobfar S.p.A.) which will expand Navamedic’s portfolio of antibiotics for hospital use. Under the agreement, Navamedic acquires the rights and Marketing Authorizations for the unique Clindamycin ready-to-administer bags developed and manufactured by InfoRLife AS. Navamedic already markets Clindamycin in traditional ampoules as part of the large portfolio of antibiotics acquired from ACS Dobfar in 2020. The innovative ready-to-use product will thus complement this portfolio.Clindamycin